# RTW Investments, LP 13F holdings Q2 2026: $11.7 billion

RTW Investments, LP reported $11.7 billion in 13F securities across 84 positions for the quarter ended June 30, 2026, in a holdings report filed August 14, 2026. Its largest holding was Madrigal Pharmaceuticals Inc at $1.1 billion, 9.1% of the reported value. Since Q1 2026 it opened 9 new positions and exited 13.

SpecStream is the live web data engine for teams and agents. It reads the SEC's Form 13F data sets each quarter, and this page is that reading, keyed on the manager's CIK and the security's CUSIP. Ask for the managers or the holdings you track, and each new 13F filing arrives in your sheet, CRM, Slack or agent as the SEC publishes it.

- Quarter: Q2 2026, the quarter ended June 30, 2026
- Reported value: $11,712,926,784
- Positions: 84
- Filed: August 14, 2026
- Report type: 13F holdings report
- CIK: 1493215
- Form 13F file number: 028-16670
- CRD number: 153232
- Business address: 40 10th Avenue 7th Floor, New York, NY 10014
- SEC filing: [0001493215-26-000164](https://www.sec.gov/Archives/edgar/data/1493215/000149321526000164/0001493215-26-000164-index.htm)
- Investment adviser record: [Form ADV on SpecStream](https://specstream.ai/data/investment-advisers/firm/rtw-investments-lp-153232)

## Top 25 holdings by value

The largest of 84 positions by reported value at the end of the quarter ended June 30, 2026. Put and call options are marked in the class. Change is in shares or principal against the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value | Change since Q1 2026 |
| --- | --- | --- | --- | --- |
| [Madrigal Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/madrigal-pharmaceuticals-inc-558868105) | COM | 1,993,687 | $1.07 billion | No change |
| [Argenx Se](https://specstream.ai/data/institutional-holders/argenx-se-04016x101) | SPONSORED ADR | 709,446 | $658.2 million | No change |
| [PTC Therapeutics Inc](https://specstream.ai/data/institutional-holders/ptc-therapeutics-inc-69366j200) | COM | 7,746,415 | $631.9 million | No change |
| [Protagonist Therapeutics Inc](https://specstream.ai/data/institutional-holders/protagonist-therapeutics-inc-74366e102) | COM | 5,061,175 | $620.4 million | +2,122 |
| [CG Oncology Inc](https://specstream.ai/data/institutional-holders/cg-oncology-inc-156944100) | COM | 8,514,590 | $605 million | +1,529,782 |
| [Insmed Inc](https://specstream.ai/data/institutional-holders/insmed-inc-457669307) | COM PAR $.01 | 4,842,880 | $516.3 million | No change |
| [Tango Therapeutics Inc](https://specstream.ai/data/institutional-holders/tango-therapeutics-inc-87583x109) | COM | 13,900,620 | $434.5 million | +600,000 |
| [Spyre Therapeutics Inc](https://specstream.ai/data/institutional-holders/spyre-therapeutics-inc-00773j202) | COM NEW | 4,251,996 | $377.5 million | +80,000 |
| [Celcuity Inc](https://specstream.ai/data/institutional-holders/celcuity-inc-15102k100) | COM | 3,304,903 | $345.8 million | +265,282 |
| [Erasca Inc](https://specstream.ai/data/institutional-holders/erasca-inc-29479a108) | COM | 17,946,754 | $328.8 million | +1,789,579 |
| [Radnet Inc](https://specstream.ai/data/institutional-holders/radnet-inc-750491102) | COM | 4,846,958 | $298.9 million | +561,958 |
| [Oruka Therapeutics Inc](https://specstream.ai/data/institutional-holders/oruka-therapeutics-inc-687604108) | COM | 3,139,030 | $298.7 million | +1,080,882 |
| [Natera Inc](https://specstream.ai/data/institutional-holders/natera-inc-632307104) | COM | 1,000,000 | $271.5 million | -250,000 |
| [Ultragenyx Pharmaceutical in](https://specstream.ai/data/institutional-holders/ultragenyx-pharmaceutical-in-90400d108) | COM | 7,796,895 | $260.3 million | +4,148,100 |
| [Irhythm Holdings Inc](https://specstream.ai/data/institutional-holders/irhythm-holdings-inc-450056106) | COM | 2,182,631 | $259.6 million | +514,131 |
| [Cytokinetics Inc](https://specstream.ai/data/institutional-holders/cytokinetics-inc-23282w605) | COM NEW | 2,862,003 | $243.8 million | +140,845 |
| [Kailera Therapeutics Inc](https://specstream.ai/data/institutional-holders/kailera-therapeutics-inc-482931102) | COMMON STOCK | 10,776,820 | $237.4 million | New |
| [Establishment Labs Hldgs Inc](https://specstream.ai/data/institutional-holders/establishment-labs-hldgs-inc-g31249108) | COM | 2,655,695 | $227.9 million | No change |
| [Guardant Health Inc](https://specstream.ai/data/institutional-holders/guardant-health-inc-40131m109) | COM | 1,481,033 | $222.2 million | No change |
| [Neurocrine Biosciences Inc](https://specstream.ai/data/institutional-holders/neurocrine-biosciences-inc-64125c109) | COM | 1,267,925 | $213.7 million | +205,853 |
| [Tarsus Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/tarsus-pharmaceuticals-inc-87650l103) | COM | 3,357,059 | $211.3 million | +11,034 |
| [Stoke Therapeutics Inc](https://specstream.ai/data/institutional-holders/stoke-therapeutics-inc-86150r107) | COM | 5,623,525 | $184 million | No change |
| [Uniqure NV](https://specstream.ai/data/institutional-holders/uniqure-nv-n90064101) | SHS | 3,941,572 | $181.5 million | +1,355,216 |
| [Acadia Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/acadia-pharmaceuticals-inc-004225108) | COM | 7,144,524 | $180.8 million | No change |
| [Repligen Corp](https://specstream.ai/data/institutional-holders/repligen-corp-759916109) | COM | 1,240,637 | $169.3 million | +34,637 |

## New positions in Q2 2026

9 positions not in the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Kailera Therapeutics Inc](https://specstream.ai/data/institutional-holders/kailera-therapeutics-inc-482931102) | COMMON STOCK | 10,776,820 | $237.4 million |
| [Structure Therapeutics Inc](https://specstream.ai/data/institutional-holders/structure-therapeutics-inc-86366e106) | SPONSORED ADS | 1,607,507 | $86.3 million |
| [Axogen Inc](https://specstream.ai/data/institutional-holders/axogen-inc-05463x106) | COM | 1,011,576 | $46.7 million |
| [Danaher Corp Del](https://specstream.ai/data/institutional-holders/danaher-corp-del-235851102) | COM | 230,000 | $43.8 million |
| [Solid Biosciences Inc](https://specstream.ai/data/institutional-holders/solid-biosciences-inc-83422e204) | COM NEW | 3,892,926 | $38.9 million |
| [Ideaya Biosciences Inc](https://specstream.ai/data/institutional-holders/ideaya-biosciences-inc-45166a102) | COM | 370,370 | $13.8 million |
| [Allogene Therapeutics Inc](https://specstream.ai/data/institutional-holders/allogene-therapeutics-inc-019770106) | COM | 3,250,000 | $6.8 million |
| [Maze Therapeutics Inc](https://specstream.ai/data/institutional-holders/maze-therapeutics-inc-578784100) | COM | 212,000 | $6.3 million |
| [Abivax SA](https://specstream.ai/data/institutional-holders/abivax-sa-00370m103) | SPONSORED ADS | 26,400 | $3.5 million |

## Positions exited in Q2 2026

13 positions in the filing for the quarter ended March 31, 2026 and not in this one, with the shares and value reported then.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Apogee Therapeutics Inc](https://specstream.ai/data/institutional-holders/apogee-therapeutics-inc-03770n101) | COM | 2,782,097 | $234.2 million |
| Apellis Pharmaceuticals Inc | COM | 3,685,045 | $148.2 million |
| [Intuitive Surgical Inc](https://specstream.ai/data/institutional-holders/intuitive-surgical-inc-46120e602) | COM NEW | 220,000 | $101.4 million |
| Centessa Pharmaceuticals PLC | SPONSORED ADS | 2,054,175 | $81.6 million |
| [Crinetics Pharmaceuticals in](https://specstream.ai/data/institutional-holders/crinetics-pharmaceuticals-in-22663k107) | COM | 1,451,326 | $52.7 million |
| [Waystar HLDG Corp](https://specstream.ai/data/institutional-holders/waystar-hldg-corp-946784105) | COM | 1,630,000 | $39.3 million |
| [Arrowhead Pharmaceuticals in](https://specstream.ai/data/institutional-holders/arrowhead-pharmaceuticals-in-04280a100) | COM | 585,682 | $36.7 million |
| [Stryker Corporation](https://specstream.ai/data/institutional-holders/stryker-corporation-863667101) | COM | 100,000 | $32.9 million |
| [Compass Therapeutics Inc](https://specstream.ai/data/institutional-holders/compass-therapeutics-inc-20454b104) | COM | 4,186,599 | $22.1 million |
| [Fulgent Genetics Inc](https://specstream.ai/data/institutional-holders/fulgent-genetics-inc-359664109) | COM | 1,289,000 | $20.5 million |
| [Jade Biosciences Inc](https://specstream.ai/data/institutional-holders/jade-biosciences-inc-008064206) | COM NEW | 573,205 | $8.1 million |
| [Inventiva SA](https://specstream.ai/data/institutional-holders/inventiva-sa-46124u107) | ADS | 1,298,702 | $7.2 million |
| [Omada Health Inc](https://specstream.ai/data/institutional-holders/omada-health-inc-68170a108) | COM | 200,000 | $2.5 million |

## Also on SpecStream

- [RTW Investments, LP Form 13F filing on EDGAR](https://www.sec.gov/Archives/edgar/data/1493215/000149321526000164/0001493215-26-000164-index.htm)
- [RTW Investments, LP investment adviser record (Form ADV)](https://specstream.ai/data/investment-advisers/firm/rtw-investments-lp-153232)
- [Largest 13F filers in New York](https://specstream.ai/data/institutional-holdings/state/new-york)
- [Largest institutional managers by 13F value](https://specstream.ai/data/institutional-holdings)
- [Most widely held securities in 13F filings](https://specstream.ai/data/institutional-holders)

Source: [the SEC's Form 13F data sets](https://www.sec.gov/data-research/sec-markets-data/form-13f-data-sets). Public data published by the US Securities and Exchange Commission (US government work). Managers report these holdings themselves in Form 13F, and the SEC does not check or guarantee them. Form 13F lists long positions in US listed equities, some options and convertible notes held at the end of the quarter, and leaves out short positions, cash, most bonds and holdings below the reporting threshold. Values are market values in US dollars as the manager filed them. A manager can ask the SEC to keep some positions confidential for a time. This page uses SEC data and is not endorsed or certified by the SEC.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in New York, New York

- [Countertop installers in New York, New York](https://specstream.ai/data/businesses/countertop-installers/new-york-new-york-united-states)
- [Mortgage brokers in New York, New York](https://specstream.ai/data/businesses/mortgage-brokers/new-york-new-york-united-states)
- [Ambulance services in New York, New York](https://specstream.ai/data/businesses/ambulance-services/new-york-new-york-united-states)
- [Gastroenterology practices in New York, New York](https://specstream.ai/data/businesses/gastroenterology-practices/new-york-new-york-united-states)
- [Real estate law firms in New York, New York](https://specstream.ai/data/businesses/real-estate-law-firms/new-york-new-york-united-states)
- [Cleaning companies in New York, New York](https://specstream.ai/data/businesses/cleaning-companies/new-york-new-york-united-states)
